recombinant human tnf rii fc chimera (R&D Systems)
Structured Review
Recombinant Human Tnf Rii Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/726-R2/Recombinant+Human+TNF+RII%2FTNFRSF1B+Fc+Chimera+Protein%2C+CF/pmc02849297-50-18-22
Average 94 stars, based on 13 article reviews
Images
Related Articles
Inhibition:Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 pg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) is coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNF-alpha-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNF-α-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Enzyme-linked Immunosorbent Assay:Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 pg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) is coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNF-alpha-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies. Article Snippet: .. Immunoreactivity to mouse TNFR2 and cross-reactivity to human TNFR2 was assessed by ELISA using recombinant mTNFR2/Fc-protein (R&D Systems, 9707-R2) and Article Title: Anti-TNF-α-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Concentration Assay:Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 pg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNFα-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) is coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNF-alpha-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/ml. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of Article Title: Anti-TNF-α-antibodies and functional fragments thereof Article Snippet: For the first inhibition ELISA, the extracellular domain of TNFRI fused to the Fc region of human IgG (R&D Systems, Cat. No. 372-RI) was coated on a 96-well Maxisorp ELISA at a concentration of 0.5 μg/mL. .. For the second inhibition ELISA, the extracellular domain of TNFRII fused to the Fc region of In Vitro:Article Title: Systematic perturbation screens decode regulators of inflammatory macrophage states and identify a role for TNF mRNA m6A modification Article Snippet: Cells were stimulated with ultrapure LPS (5 ng/ml unless specified otherwise) (E.coli 0111:B4, Invitrogen), recombinant human IFN-γ (2 ng/ml) (285-IF-100, R&D Systems), recombinant human TNFα (10 ng/ml) (10291-TA-020, R&D Systems), poly I:C (1μg / ml) (tlrI-pic, Invitrogen), R848 (1μg / ml) (tlrI-r848, Invitrogen), recombinant mouse IFN-γ (20 ng/ml) (485-MI-100, R&D Systems), recombinant mouse TNFα (5 ng/ml). (410-MT-010/CF, R&D Systems), recombinant mouse IL1b (20 ng/ml) (401-ML-005/CF, R&D Systems) at indicated time points and concentrations. .. In vitro TNFα-blocking studies were performed using recombinant human TNFRII/TNFRSF1B-Fc chimera protein (1 μg / ml) ( Recombinant:Article Title: Systematic perturbation screens decode regulators of inflammatory macrophage states and identify a role for TNF mRNA m6A modification Article Snippet: Cells were stimulated with ultrapure LPS (5 ng/ml unless specified otherwise) (E.coli 0111:B4, Invitrogen), recombinant human IFN-γ (2 ng/ml) (285-IF-100, R&D Systems), recombinant human TNFα (10 ng/ml) (10291-TA-020, R&D Systems), poly I:C (1μg / ml) (tlrI-pic, Invitrogen), R848 (1μg / ml) (tlrI-r848, Invitrogen), recombinant mouse IFN-γ (20 ng/ml) (485-MI-100, R&D Systems), recombinant mouse TNFα (5 ng/ml). (410-MT-010/CF, R&D Systems), recombinant mouse IL1b (20 ng/ml) (401-ML-005/CF, R&D Systems) at indicated time points and concentrations. .. In vitro TNFα-blocking studies were performed using recombinant human TNFRII/TNFRSF1B-Fc chimera protein (1 μg / ml) ( Article Title: Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies. Article Snippet: .. Immunoreactivity to mouse TNFR2 and cross-reactivity to human TNFR2 was assessed by ELISA using recombinant mTNFR2/Fc-protein (R&D Systems, 9707-R2) and Activation Assay:Article Title: Systematic perturbation screens decode regulators of inflammatory macrophage states and identify a role for TNF mRNA m6A modification Article Snippet: HUVECs were obtained from Lonza and cultured in EGM-2 Endothelial cell growth medium-2 bullet kit (Lonza, CC-3162) supplemented with penicillin-streptomycin and glutamine on gelatin coated plates (Millipore Sigma, ES-006-B). .. For activation endothelial cells were incubated with hMDM conditioned media for 6 h in absence or presence of Incubation:Article Title: Systematic perturbation screens decode regulators of inflammatory macrophage states and identify a role for TNF mRNA m6A modification Article Snippet: HUVECs were obtained from Lonza and cultured in EGM-2 Endothelial cell growth medium-2 bullet kit (Lonza, CC-3162) supplemented with penicillin-streptomycin and glutamine on gelatin coated plates (Millipore Sigma, ES-006-B). .. For activation endothelial cells were incubated with hMDM conditioned media for 6 h in absence or presence of |
